Effects of ACEI and ARB Continuation or Discontinuation on Outcomes in Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial
JAMA 2021 Jan 19;325(3)254-264, RD Lopes, AVS Macedo, PGM de Barros E Silva, RJ Moll-Bernardes, TM Dos Santos, L Mazza, A Feldman, G D'Andréa Saba Arruda, DC de Albuquerque, AS Camiletti, AS de Sousa, TC de Paula, KGD Giusti, RAM Domiciano, MM Noya-Rabelo, AM Hamilton, VA Loures, RM Dionísio, TAB Furquim, FA De Luca, ÍB Dos Santos Sousa, BS Bandeira, CN Zukowski, RGG de Oliveira, NB Ribeiro, JL de Moraes, JLF Petriz, AM Pimentel, JS Miranda, BE de Jesus Abufaiad, CM Gibson, CB Granger, JH Alexander, OF de SouzaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.